glp-1 vs sglt2 diabetes for CKD: Which Is Better? SGLT2i and GLP-1 RA therapy

Dosing Protocol Evidence-based weekly titration approach from clinical trials

Support brighter, healthier-looking skin from within without relying only on multiple creams, expensive treatments, or lengthy skincare routines

The US market is also witnessing a pivotal affordability shift

Consistent with the base-case analysis, sensitivity analyses demonstrated that using GLP-1RAs versus insulin was either cost-saving or cost-effective, except for the analyses where the treatment effectiveness was estimated based on the AT scenario in the second and third sensitivity analyses, showing that a GLP-1RA versus insulin therapy was not cost-effective for averting one case of all-cause death from the payer perspective

DOI: 10.1002/14651858.CD012530

Stay Social With Us!